- Home
- FHN vs SNN Comparison
FHN vs SNN Comparison
Compare FHN & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- SNN
- Stock Information
- Founded
- FHN 1864
- SNN 1856
- Country
- FHN United States
- SNN United Kingdom
- Employees
- FHN N/A
- SNN N/A
- Industry
- FHN Major Banks
- SNN Industrial Specialties
- Sector
- FHN Finance
- SNN Health Care
- Exchange
- FHN Nasdaq
- SNN Nasdaq
- Market Cap
- FHN 10.4B
- SNN 11.0B
- IPO Year
- FHN N/A
- SNN 1999
- Fundamental
- Price
- FHN $21.55
- SNN $25.30
- Analyst Decision
- FHN Buy
- SNN Strong Buy
- Analyst Count
- FHN 16
- SNN 1
- Target Price
- FHN $21.34
- SNN N/A
- AVG Volume (30 Days)
- FHN 5.9M
- SNN 1.1M
- Earning Date
- FHN 01-16-2025
- SNN 02-25-2025
- Dividend Yield
- FHN 2.78%
- SNN 2.97%
- EPS Growth
- FHN N/A
- SNN 39.77
- EPS
- FHN 1.36
- SNN 0.35
- Revenue
- FHN $3,040,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- FHN N/A
- SNN $6.24
- Revenue Next Year
- FHN $2.23
- SNN $4.92
- P/E Ratio
- FHN $15.85
- SNN $35.74
- Revenue Growth
- FHN 1.95
- SNN 5.48
- 52 Week Low
- FHN $13.45
- SNN $23.65
- 52 Week High
- FHN $21.72
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- FHN 65.64
- SNN 57.67
- Support Level
- FHN $20.37
- SNN $23.69
- Resistance Level
- FHN $21.62
- SNN $24.82
- Average True Range (ATR)
- FHN 0.53
- SNN 0.44
- MACD
- FHN 0.12
- SNN 0.13
- Stochastic Oscillator
- FHN 96.37
- SNN 47.20
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The regional bank is responsible for roughly 65% of its revenue, while capital markets make a 25% contribution. The remainder is split between the firm's non-strategic (wind-down) and corporate operations. First Horizon concentrates on offering a variety of banking products mainly in its home state, where it has the second- largest deposit franchise with a 13% deposit market share.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.